コリナージックニューロンの活動が,マスカリンシグナル伝達により,拡散性ミドルライン・グリオマの成長を促進する
Richard Drexler1, Antonia Drinnenberg2, Avishai Gavish3
1Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA 94305, USA.
Cell
|June 20, 2025
まとめ
中脳コレリン神経は,拡散性ミッドライン・グリオマ (DMG) の成長とオリゴデンドロサイト前駆体細胞 (OPC) の増殖を促進する. この効果は回路に依存し,DMG細胞のM1/M3受容体に作用するアセチルコリンによって媒介される.
科学分野:
- 神経科学
- 腫瘍学
- 細胞生物学
背景:
- グルタマタージック活動はオリゴデンドロサイト前駆細胞 (OPC) とグリオマの増殖に影響する.
- 脳幹神経調節性ニューロンの作用は,拡散性ミッドライン・グリオマ (DMG) の発現において不明である.
研究 の 目的:
- OPCとDMGの増殖に対する中脳ホリナージックニューロン活動の影響を調査する.
- コリン発射がグリオマの成長に影響を与える回路特有のメカニズムを解明する.
主な方法:
- 特定の中脳コレリン核 (PPN,LDT) の光遺伝的刺激
- DMGのインビヴォとインビトロ共同培養モデル
- 単細胞RNAの配列化により,受容体の発現を特定する.
- M1/M3受容体の薬理学的および遺伝的阻害
主要な成果:
- コリナージック・ペドンキュロポンチン核 (PPN) 刺激はポンチン膠原腫の成長を促進し,横背側膜核 (LDT) 刺激はタラミック膠原腫の成長を促進した.
- DMGを投与したマウスはアセチルコリン放出とコレリン活性が増加した.
- CHRM1およびCHRM3受容体を通してDMG細胞に直接作用するアセチルコリンは,共培養におけるDMG増殖を強めた.
- M1/M3受容体の阻害により,コレリン作用によるDMG増殖は廃止された.
結論:
- 中脳ホルモン投射は,回路特異的な方法で活動に依存するDMGの増殖を促進する.
- このメカニズムは,健康なOPCに対する増殖効果を反映しています.
- M1/M3受容体をターゲットにすることで,DMGの治療戦略を提供することができる.
関連する概念動画
Cholinergic Receptors: Muscarinic
3.3K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
3.3K
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.6K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.6K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
854
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
854
Cholinergic Antagonists: Pharmacological Actions
1.3K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.3K
Parasympathetic Signaling
2.2K
Parasympathetic signaling plays a crucial role in regulating various physiological processes. It involves the release of acetylcholine (ACh) by parasympathetic neurons, which can have localized and short-lived effects. The majority of ACh released is rapidly inactivated at the synapse by the enzyme acetylcholinesterase (AChE), which hydrolyzes Ach into choline and acetate. Additionally, the tissue cholinesterase deactivates any ACh diffusing into the surrounding tissues.
The effects of...
The effects of...
2.2K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
915
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
915


